Colorectal, Gastroesophageal and Pancreatic Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Colorectal, Gastroesophageal and Pancreatic Cancer
Proceedings from a CME symposium held at the 2020 Gastrointestinal Cancers Symposium. Featuring perspectives from Drs Crystal Denlinger, Howard S Hochster, John L Marshall, Michael J Overman, Philip A Philip and Prof Eric Van Cutsem.
Introduction — Dr Neil Love (00:00)
The Emergence of Targeted Therapy for Patients with Metastatic Colorectal Cancer (mCRC) and BRAF V600E Tumor Mutations; HER2 and Other Potential Biomarkers — Dr Hochster (16:20)
Lingering Questions in the Selection and Sequence of Therapy for Patients with mCRC — Dr Marshall (44:23)
Current and Emerging Role of Immune Checkpoint Inhibitors in the Management of mCRC — Dr Overman (1:05:39)
Optimal Management of Metastatic Gastric/Gastroesophageal Cancer — Dr Denlinger (1:33:29)
Contemporary Treatment Approaches for Patients with Pancreatic Cancer — Dr Philip (1:53:28)
PARP Inhibition in Pancreatic Cancer; Promising Investigational Strategies — Prof Van Cutsem (2:15:15)
Podden och tillhörande omslagsbild på den här sidan tillhör Dr Neil Love. Innehållet i podden är skapat av Dr Neil Love och inte av, eller tillsammans med, Poddtoppen.
